A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
Atherosclerotic cardiovascular disease (ASCVD), including coronary artery disease, cerebrovascular disease, and peripheral artery disease, carries a high morbidity and mortality. Risk factor control is especially important for patients with ASCVD to reduce recurrent cardiovascular events. Clinical g...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-03-01
|
| Series: | Journal of the Formosan Medical Association |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664619300038 |
| _version_ | 1818290455242080256 |
|---|---|
| author | Yi-Heng Li Jaw-Wen Chen Tsung-Hsien Lin Yu-Chen Wang Chau-Chung Wu Hung-I Yeh Chin-Chou Huang Kuan-Cheng Chang Cho-Kai Wu Po-Wei Chen Chen-Wei Huang Zhih-Cherng Chen Wei-Ting Chang Wei-Chun Huang Chih-Yuan Wang Mei-Yueh Lee A-Ching Chao Wei-Ren Fu Li-Kai Tsai Sung-Chun Tang Hsin-Lung Chan Yi-Ching Yang Yen-Wen Wu Juey-Jen Hwang Jiunn-Lee Lin |
| author_facet | Yi-Heng Li Jaw-Wen Chen Tsung-Hsien Lin Yu-Chen Wang Chau-Chung Wu Hung-I Yeh Chin-Chou Huang Kuan-Cheng Chang Cho-Kai Wu Po-Wei Chen Chen-Wei Huang Zhih-Cherng Chen Wei-Ting Chang Wei-Chun Huang Chih-Yuan Wang Mei-Yueh Lee A-Ching Chao Wei-Ren Fu Li-Kai Tsai Sung-Chun Tang Hsin-Lung Chan Yi-Ching Yang Yen-Wen Wu Juey-Jen Hwang Jiunn-Lee Lin |
| author_sort | Yi-Heng Li |
| collection | DOAJ |
| description | Atherosclerotic cardiovascular disease (ASCVD), including coronary artery disease, cerebrovascular disease, and peripheral artery disease, carries a high morbidity and mortality. Risk factor control is especially important for patients with ASCVD to reduce recurrent cardiovascular events. Clinical guidelines have been developed by the Taiwan Society of Cardiology, Taiwan Society of Lipids and Atherosclerosis, and Diabetes Association of Republic of China (Taiwan) to assist health care professionals in Taiwan about the control of hypertension, hypercholesterolemia and diabetes mellitus. This article is to highlight the recommendations about blood pressure, cholesterol, and sugar control for ASCVD. Some medications that are beneficial for ASCVD were also reviewed. We hope the clinical outcomes of ASCVD can be improved in Taiwan through the implementation of these recommendations. Keywords: Atherosclerosis, Risk factors, Performance guide |
| first_indexed | 2024-12-13T02:28:26Z |
| format | Article |
| id | doaj.art-e3016cb606d84ffaac89e75f325f53eb |
| institution | Directory Open Access Journal |
| issn | 0929-6646 |
| language | English |
| last_indexed | 2024-12-13T02:28:26Z |
| publishDate | 2020-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of the Formosan Medical Association |
| spelling | doaj.art-e3016cb606d84ffaac89e75f325f53eb2022-12-22T00:02:35ZengElsevierJournal of the Formosan Medical Association0929-66462020-03-011193674684A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in TaiwanYi-Heng Li0Jaw-Wen Chen1Tsung-Hsien Lin2Yu-Chen Wang3Chau-Chung Wu4Hung-I Yeh5Chin-Chou Huang6Kuan-Cheng Chang7Cho-Kai Wu8Po-Wei Chen9Chen-Wei Huang10Zhih-Cherng Chen11Wei-Ting Chang12Wei-Chun Huang13Chih-Yuan Wang14Mei-Yueh Lee15A-Ching Chao16Wei-Ren Fu17Li-Kai Tsai18Sung-Chun Tang19Hsin-Lung Chan20Yi-Ching Yang21Yen-Wen Wu22Juey-Jen Hwang23Jiunn-Lee Lin24Division of Cardiology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, TaiwanDepartment of Medical Research and Education, Taipei Veterans General Hospital and Institute of Pharmacology, National Yang Ming University, Taipei, TaiwanDivision of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital and Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanDivision of Cardiology, Department of Internal Medicine, Asia University Hospital, China Medical University College of Medicine and Hospital, Taichung, TaiwanDivision of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and Graduate Institute of Medical Education & Bioethics, College of Medicine, National Taiwan University, Taipei, TaiwanDepartment of Internal Medicine and Medical Research, Mackay Memorial Hospital, Taipei, Taiwan; Department of Medicine, Mackay Medical College, New Taipei City, TaiwanDepartment of Medical Education, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Cardiovascular Research Center, National Yang-Ming University, Taipei, TaiwanDivision of Cardiovascular Medicine, Department of Internal Medicine, China Medical University Hospital and College of Medicine, China Medical University, Taichung, TaiwanDivision of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, TaiwanDivision of Cardiology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, TaiwanDivision of Cardiology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, TaiwanDivision of Cardiology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan; Department of Pharmacy, Chia Nan University of Pharmacy & Science, Tainan, TaiwanDivision of Cardiology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, TaiwanDivision of Cardiology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, TaiwanDivision of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei, TaiwanDivision of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Taiwan; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanDepartment of Neurology, Kaohsiung Medical University Hospital, Taiwan; Graduate Institute of Clinical Medicine and Department of Neurology, College of Medicine, Kaohsiung Medical University, Kaohsiung, TaiwanDepartment of Neurology, Mackay Memorial Hospital, Taipei, TaiwanStroke Center and Department of Neurology, National Taiwan University Hospital, Taipei, TaiwanStroke Center and Department of Neurology, National Taiwan University Hospital, Taipei, TaiwanDepartment of Family Medicine, Mackay Memorial Hospital, Department of Medicine, Mackay Medical College, Taipei, TaiwanDepartment of Family Medicine, National Cheng Kung University Hospital, Department of Family Medicine, College of Medicine, National Cheng Kung University, Tainan, TaiwanCardiology Division, Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei City, Taiwan; National Yang-Ming University School of Medicine, Taipei, TaiwanCardiology Division, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital Yun-Lin, Yun-Lin, Taiwan; Corresponding author. Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei, Taiwan.Cardiology Division, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Division of Cardiovascular Medicine, Department of Internal Medicine, Taipei Medical University Shuang Ho Hospital, New Taipei City, Taiwan; Corresponding author. Cardiovascular Center, Taipei Medical University Shuang Ho Hospital, No. 291 Zhong-zheng Road, Zhonghe District, New Taipei City, Taiwan.Atherosclerotic cardiovascular disease (ASCVD), including coronary artery disease, cerebrovascular disease, and peripheral artery disease, carries a high morbidity and mortality. Risk factor control is especially important for patients with ASCVD to reduce recurrent cardiovascular events. Clinical guidelines have been developed by the Taiwan Society of Cardiology, Taiwan Society of Lipids and Atherosclerosis, and Diabetes Association of Republic of China (Taiwan) to assist health care professionals in Taiwan about the control of hypertension, hypercholesterolemia and diabetes mellitus. This article is to highlight the recommendations about blood pressure, cholesterol, and sugar control for ASCVD. Some medications that are beneficial for ASCVD were also reviewed. We hope the clinical outcomes of ASCVD can be improved in Taiwan through the implementation of these recommendations. Keywords: Atherosclerosis, Risk factors, Performance guidehttp://www.sciencedirect.com/science/article/pii/S0929664619300038 |
| spellingShingle | Yi-Heng Li Jaw-Wen Chen Tsung-Hsien Lin Yu-Chen Wang Chau-Chung Wu Hung-I Yeh Chin-Chou Huang Kuan-Cheng Chang Cho-Kai Wu Po-Wei Chen Chen-Wei Huang Zhih-Cherng Chen Wei-Ting Chang Wei-Chun Huang Chih-Yuan Wang Mei-Yueh Lee A-Ching Chao Wei-Ren Fu Li-Kai Tsai Sung-Chun Tang Hsin-Lung Chan Yi-Ching Yang Yen-Wen Wu Juey-Jen Hwang Jiunn-Lee Lin A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan Journal of the Formosan Medical Association |
| title | A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan |
| title_full | A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan |
| title_fullStr | A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan |
| title_full_unstemmed | A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan |
| title_short | A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan |
| title_sort | performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in taiwan |
| url | http://www.sciencedirect.com/science/article/pii/S0929664619300038 |
| work_keys_str_mv | AT yihengli aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT jawwenchen aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT tsunghsienlin aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT yuchenwang aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT chauchungwu aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT hungiyeh aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT chinchouhuang aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT kuanchengchang aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT chokaiwu aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT poweichen aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT chenweihuang aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT zhihcherngchen aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT weitingchang aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT weichunhuang aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT chihyuanwang aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT meiyuehlee aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT achingchao aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT weirenfu aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT likaitsai aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT sungchuntang aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT hsinlungchan aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT yichingyang aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT yenwenwu aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT jueyjenhwang aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT jiunnleelin aperformanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT yihengli performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT jawwenchen performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT tsunghsienlin performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT yuchenwang performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT chauchungwu performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT hungiyeh performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT chinchouhuang performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT kuanchengchang performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT chokaiwu performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT poweichen performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT chenweihuang performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT zhihcherngchen performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT weitingchang performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT weichunhuang performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT chihyuanwang performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT meiyuehlee performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT achingchao performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT weirenfu performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT likaitsai performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT sungchuntang performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT hsinlungchan performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT yichingyang performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT yenwenwu performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT jueyjenhwang performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan AT jiunnleelin performanceguideformajorriskfactorscontrolinpatientswithatheroscleroticcardiovasculardiseaseintaiwan |